Michael Schröter

6.7k total citations · 3 hit papers
15 papers, 5.5k citations indexed

About

Michael Schröter is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Michael Schröter has authored 15 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Immunology and 4 papers in Oncology. Recurrent topics in Michael Schröter's work include Cell death mechanisms and regulation (10 papers), Immunotherapy and Immune Responses (3 papers) and Autophagy in Disease and Therapy (2 papers). Michael Schröter is often cited by papers focused on Cell death mechanisms and regulation (10 papers), Immunotherapy and Immune Responses (3 papers) and Autophagy in Disease and Therapy (2 papers). Michael Schröter collaborates with scholars based in Switzerland, Germany and United States. Michael Schröter's co-authors include Pascal Schneider, Michael Hahne, Jürg Tschopp, Lars E. French, Kay Hofmann, Donata Rimoldi, Margot Thome, Kim Burns, Martin Irmler and Chantal Mattmann and has published in prestigious journals such as Nature, Science and The Journal of Experimental Medicine.

In The Last Decade

Michael Schröter

15 papers receiving 5.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Inhibition of death receptor signals by cellular FLIP

1997 2.1k citations Martin Irmler, Margot Thome et al. Nature profile →
Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors

1997 1.1k citations Margot Thome, Pascal Schneider et al. Nature profile →
Melanoma Cell Expression of Fas(Apo-1/CD95) Ligand: Implications for Tumor Immune Escape

1996 1.1k citations Michael Hahne, Donata Rimoldi et al. Science profile →

Peers

Countries citing papers authored by Michael Schröter

Since Specialization

Citations

This map shows the geographic impact of Michael Schröter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Schröter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Schröter more than expected).

Fields of papers citing papers by Michael Schröter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Schröter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Schröter. The network helps show where Michael Schröter may publish in the future.

Co-authorship network of co-authors of Michael Schröter

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Schröter. A scholar is included among the top collaborators of Michael Schröter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Schröter. Michael Schröter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Comparison of Pantoprazole Concentrations in Simultaneous Cerebrospinal Fluid and Serum Samples 2016 ·Pharmacology ·(unknown), (unknown), Tina Braun, Sebastian Frechen, S. Hüttner, Michael Schröter, Martina Kinzig, Uwe Fuhr, Ulrike Holzgrabe, Fritz Sörgel	2
2	Fas-dependent tissue turnover is implicated in tumor cell clearance 2000 ·Oncogene ·Michael Schröter, J. Péli, Michael Hahne, Jürg Tschopp, Ernst Reichmann	15
3	APRIL, a New Ligand of the Tumor Necrosis Factor Family, Stimulates Tumor Cell Growth 1998 ·The Journal of Experimental Medicine ·Michael Hahne, Takao Kataoka, Michael Schröter, Kay Hofmann, Martin Irmler, Jean-Luc Bodmer, Pascal Schneider, (unknown), Nils Holler, Lars E. French, Bernard Sordat, Donata Rimoldi, Jürg Tschopp	431
4	FLIP Prevents Apoptosis Induced by Death Receptors But Not by Perforin/Granzyme B, Chemotherapeutic Drugs, and Gamma Irradiation 1998 ·The Journal of Immunology ·Takao Kataoka, Michael Schröter, Michael Hahne, Pascal Schneider, Martin Irmler, Margot Thome, (unknown), Jürg Tschopp	193
5	The resolution of lesions induced by Leishmania major in mice requires a functional Fas (APO-1, CD 95) pathway of cytotoxicity 1998 ·European Journal of Immunology ·Fátima Conceição‐Silva, Michael Hahne, Michael Schröter, Jacques Louis, Jürg Tschopp	3
6	The resolution of lesions induced byLeishmania major in mice requires a functional Fas (APO-1, CD 95) pathway of cytotoxicity 1998 ·European Journal of Immunology ·Fátima Conceição‐Silva, Michael Hahne, Michael Schröter, Jacques Louis, Jürg Tschopp	73
7	Validity of new immunological human fecal hemoglobin and albumin tests in detecting colorectal neoplasms--an endoscopy-controlled study. 1998 ·PubMed ·Andreas Sieg, (unknown), Markus R. John, A. Hertel, Michael Schröter, (unknown), H. Schmidt‐Gayk	10
8	Inhibition of death receptor signals by cellular FLIP breakdown → 1997 ·Nature ·Martin Irmler, Margot Thome, Michael Hahne, Pascal Schneider, Kay Hofmann, (unknown), Jean-Luc Bodmer, Michael Schröter, Kim Burns, Chantal Mattmann, Donata Rimoldi, Lars E. French, Jürg Tschopp	2123
9	Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors breakdown → 1997 ·Nature ·Margot Thome, Pascal Schneider, Kay Hofmann, Helmut Fickenscher, Edgar Meinl, Frank Neipel, Chantal Mattmann, Kim Burns, Jean-Luc Bodmer, Michael Schröter, Carsten Scaffidi, Peter H. Krammer, Marcus E. Peter, Jürg Tschopp	1066
10	TRAMP, a Novel Apoptosis-Mediating Receptor with Sequence Homology to Tumor Necrosis Factor Receptor 1 and Fas(Apo-1/CD95) 1997 ·Immunity ·Jean-Luc Bodmer, Kim Burns, Pascal Schneider, Kay Hofmann, (unknown), Margot Thome, Thierry Bornand, Michael Hahne, Michael Schröter, Karin Becker, Anne Wilson, Lars E. French, Jeffrey L. Browning, Heather Macdonald, Jürg Tschopp	233
11	Involvement of the proteasome in the programmed cell death of NGF-deprived sympathetic neurons. 1996 ·The EMBO Journal ·Rémy Sadoul, Pierre-Alain Fernandez, Anne‐Lise Quiquerez, Isabelle Martinou, M. Maki, Michael Schröter, J. David Becherer, Martin Irmler, J Tschopp, Jean‐Claude Martinou	233
12	Melanoma Cell Expression of Fas(Apo-1/CD95) Ligand: Implications for Tumor Immune Escape breakdown → 1996 ·Science ·Michael Hahne, Donata Rimoldi, Michael Schröter, Pedro Romero, Max H. Schreier, Lars E. French, Pascal Schneider, Thierry Bornand, A. Fontana, D Liénard, J C Cerottini, J Tschopp	1052
13	Increased p34cdc2-dependent kinase activity during apoptosis: a possible activation mechanism of DNase I leading to DNA breakdown. 1996 ·PubMed ·Michael Schröter, Manuel C. Peitsch, J Tschopp	12
14	Regulation of Fas(Apo‐1/CD95)‐ and perforinmediated lytic pathways of primary cytotoxic T lymphocytes by the protooncogene bcl‐2 1995 ·European Journal of Immunology ·Michael Schröter, Bente Lowin, Christoph Borner, Jürg Tschopp	49
15	Characterization of the non-functional Fas ligand of gld mice 1995 ·International Immunology ·Michael Hahne, Manuel C. Peitsch, Martin Irmler, Michael Schröter, (unknown), (unknown), Claude Bron, Toufic Renno, Lars E. French, Jürg Tschopp	53

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact